Family endogenous gipertriglitseridemiya
Contents:
- Description
- Symptoms of the Family endogenous gipertriglitseridemiya
- Reasons of the Family endogenous gipertriglitseridemiya
- Treatment of the Family endogenous gipertriglitseridemiya
- a href="javascript:if(confirm(%27medicalmeds.eu/consult_new.php?src_razd=bolezn&src_id=2545&vc_spec=16 \n\nThis file was not retrieved by Teleport Pro, because it is addressed on a path excluded by the site\%27s Robot Exclusion parameters. (Teleport Pro\%27s compliance with this system is optional; see the Project Properties, Netiquette page.) \n\nDo you want to open it from the server?%27))window.location=%27medicalmeds.eu/consult_new.php?src_razd=bolezn&src_id=2545&vc_spec=16%27" tppabs="medicalmeds.eu/consult_new.php?src_razd=bolezn&src_id=2545&vc_spec=16">
Description:
The family endogenous gipertriglitseridemiya meets about 1 of 300 people and is characterized by increase in the LPONP level (the IV giperlipoproteidemiya). Level of triglycerides usually makes from 200 to 500 mg/dl (2,3-5,7 mmol/l), the content of cholesterol normal or is slightly increased, and the level of LPNP cholesterol is lowered.
Symptoms of the Family endogenous gipertriglitseridemiya:
At a family endogenous gipertriglitseridemiya Vtipa giperlipoproteidemiya with the content of triglycerides more than 1000 mg/dl (11,3 mmol/l) and a hypercholesterolemia is found. At this option of a family endogenous gipertriglitseridemiya the risk of coronary heart disease is considerably increased. Besides, there is a danger of development of acute pancreatitis.
Reasons of the Family endogenous gipertriglitseridemiya:
It is transferred on autosomal dominantly type, meets frequency of 1:500. At heterozygous find 2-and 3-fold increase in content of cholesterol and LPNP in a blood plasma.
Treatment of the Family endogenous gipertriglitseridemiya:
Treatment consists in purpose of a hypocholesteric diet, and also the pitches connecting bile acids (холестирамин or колестипол), and GMG-KOA-reduktazy inhibitors (ловастатин, провастатин, симвастатин).